HPV Vaccine Dosing Schedule
The HPV vaccine requires either 2 or 3 doses depending on the age at which vaccination is initiated. For individuals starting vaccination before their 15th birthday, a 2-dose schedule is recommended, while those starting at age 15 or older require 3 doses 1, 2, 3.
Age-Based Dosing Algorithm
Children and Adolescents Starting Before Age 15
- 2 doses total 1, 2, 3
- Timing: Second dose administered 6-12 months after the first dose
- This applies to routine vaccination at ages 11-12 years (can start as early as age 9)
- The robust immune response in younger individuals allows for fewer doses
Adolescents and Adults Starting at Age 15 or Older
- 3 doses total 4, 3
- Standard schedule: 0,1-2, and 6 months
- Original schedule: 0,2, and 6 months
- Minimum intervals: 4 weeks between doses 1 and 2; 12 weeks between doses 2 and 3
Immunocompromised Individuals
- 3 doses regardless of age at initiation 3
- Same timing schedule as above
Key Clinical Considerations
Interrupted schedules do not require restarting the series 4. If interrupted after the first dose, give the second dose as soon as possible and ensure at least 12 weeks separate the second and third doses (if 3 doses needed).
The shift from 3 doses to 2 doses for younger recipients occurred in October 2016 when the FDA approved this schedule based on evidence showing higher antibody responses in 9-14 year-olds compared to older individuals 1. This age-dependent immune response is the biological rationale for the different dosing schedules.
Catch-up vaccination is recommended through age 26 years for anyone not adequately vaccinated 3, 5. For adults aged 27-45 years, the ACIP recommends shared clinical decision-making, though the American Cancer Society does not endorse this due to low effectiveness in this age group 5.
Emerging Evidence on Single-Dose Regimens
Recent research suggests single-dose HPV vaccination may provide substantial protection 6, 7, and the WHO proposed a single-dose strategy in 2022 8, 9. However, current FDA-approved and guideline-recommended schedules remain 2 or 3 doses depending on age at initiation 3, 5. Single-dose regimens are not yet standard practice in the United States.